Quick Answer
BioRestorative Therapies, Inc. reported Gross Profit of $335.9 thousand for fiscal year 2025.
BioRestorative Therapies, Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $335.9K | -9.9% |
| 2024 | $372.9K | +155.8% |
| 2023 | $145.8K | +80.0% |
| 2017 | $81.0K | +123.4% |
| 2016 | $36.3K | -90.1% |
| 2015 | $367.4K | +81.7% |
| 2014 | $202.2K | +13633.8% |
| 2013 | $1.5K | -89.7% |
| 2012 | $14.3K | — |
| 2011 | $0.00 | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.2K | -99.4% | -99.6% |
| June 30, 2025 | $294.6K | +256.6% | +1233.4% |
| March 31, 2025 | $22.1K | -36.9% | -89.7% |
| September 30, 2024 | $215.4K | +601.5% | +160.7% |
| June 30, 2024 | $82.6K | +28.1% | +136.0% |
| March 31, 2024 | $35.0K | — | +14.0% |
| September 30, 2023 | $30.7K | — | -52.4% |
| June 30, 2023 | $64.5K | — | +303.1% |
- BioRestorative Therapies, Inc. showed a decrease of -9.9% in Gross Profit compared to the prior fiscal year.
- The most recent figure is from BioRestorative Therapies, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: